Minimally invasive palliative treatment of malignant tracheoesophageal fistula using cardiac septal occluder - Top-Institutions - MDSpire

Minimally invasive palliative treatment of malignant tracheoesophageal fistula using cardiac septal occluder

  • By

  • Lin Teng

  • Fei Zhou

  • Xiaoqi Xiong

  • Haoyu Zhang

  • Linchen Qiao

  • Zaiqiang Zhang

  • Qin Qin

  • Xinyu Song

  • June 1, 2024

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Thoracic Surgery
    • Interventional Pulmonology
    • Oncology

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Thoracic Surgery
    • Interventional Pulmonology
    • Gastroenterology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Surgery
    • Oncology
    • Interventional Pulmonology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Thoracic Surgery
    • Interventional Pulmonology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Thoracic Surgery
    • Interventional Pulmonology
    • Gastroenterology

Original Source(s)

Minimally invasive palliative treatment of malignant tracheoesophageal fistula using cardiac septal occluder

  • by Lin Teng, Fei Zhou, Xiaoqi Xiong, Haoyu Zhang, Linchen Qiao, Zaiqiang Zhang, Qin Qin, Xinyu Song

  • June 1, 2024

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Trauma CT and Unexpected Findings

Investigators evaluate classification of incidental findings on trauma whole-body CT.

Assessing the Impact of Plasma Cell-Free DNA Methylation Monitoring on Predicting Pathological Outcomes in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer: Insights from a Prospective Phase II Study